Propanc reports preclinical pancreatic cancer data for PRP drug candidate
Go back to Propanc reports preclinical pancreatic cancer data for PRP drug candidate| (NASDAQ: PPCB) | Delayed: 1.01 -0.01 (0.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.02 | 52 Week High | $ | |||
| Open | $1.05 | 52 Week Low | $ | |||
| Day High | $1.05 | P/E | N/A | |||
| Day Low | $0.97 | EPS | $ | |||
| Volume | 194,403 | |||||

